Paneni, Francesco

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy

Autophagy in Disease and TherapyCalcium signaling and nucleotide metabolism

Cited by 2,897

The Aging Cardiovascular System

Paneni, F., Diaz Cañestro, C., Libby, P., Lüscher, T. F., & Camici, G. G. (2017) · Journal of the American College of Cardiology

Cardiovascular Health and Disease PreventionNitric Oxide and Endothelin Effects

Cited by 618

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II

Beckman, J. A., Paneni, F., Cosentino, F., & Creager, M. A. (2013) · European Heart Journal

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 434

SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory

Paneni, F., Volpe, M., Lüscher, T. F., & Cosentino, F. (2013) · Diabetes

Sirtuins and Resveratrol in MedicineAdvanced Glycation End Products research

Cited by 118

Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes

Paneni, F., & Lüscher, T. F. (2017) · The American Journal of Cardiology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 83

Epigenetic Signatures and Vascular Risk in Type 2 Diabetes: A Clinical Perspective

Paneni, F., Costantino, S., Volpe, M., Lüscher, T. F., & Cosentino, F. (2013) · Atherosclerosis

Epigenetics and DNA MethylationDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

p66Shc-induced redox changes drive endothelial insulin resistance

Paneni, F., Costantino, S., & Cosentino, F. (2014) · Atherosclerosis

Nitric Oxide and Endothelin EffectsRedox biology and oxidative stress

Cited by 38

Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures

Pugliese, N. R., Paneni, F., Tricò, D., Bacca, A. V., De Biase, N., Dalpiaz, H., Mengozzi, A., Virdis, A., Ghiadoni, L., Taddei, S., et al. (2025) · Cardiovascular Diabetology

Heart Failure Treatment and ManagementCardiovascular Disease and Adiposity

Cited by 16

Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation

Velagapudi, S., Miranda, M. X., Adla, P., Kraler, S., Mohammed, S. A., Baki, S., Robert, J., Rohrer, L., Lee, H., Jang, H.-D., et al. (2025) · Cardiovascular Research

Sirtuins and Resveratrol in MedicineCholesterol and Lipid Metabolism

Cited by 4